OPTIMIRA
Dead / Abandoned — Abandoned — no statement of use filed (as of 08 Aug 2011)
What this means for you
This application is over — abandoned 08 Aug 2011. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 77396174
- Mark type
- Stylized text
- Filed
- 13 Feb 2008
- Published for opposition
- 10 Mar 2009
- Abandoned
- 08 Aug 2011
- Attorney of record
- Jeffrey M. Gitchel
Goods and services
- Class 001 — Chemicals: Chemicals used in industry and science, namely, biologically active substances in the nature of proteins and nucleic acids, having affine and/or enzymatic properties, including enzymes and ribozymes; kits comprised of chemical reagents and assays for use in molecular-biological research
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations and diagnostic agents, with a base of biologically active substances in the nature of proteins and nucleic acids, all for use in treating autoimmune and inflammation diseases, diseases of blood and lymphatic system, cancer, cardiovascular and circulatory diseases, diseases of the central nervous system, dental diseases, dermatology disorders, diseases of the digestive system, genetic diseases, infections, diseases of the kidney and genitourinary system, metabolic diseases, endocrinology diseases, musculoskeletal disorders, ophthalmology diseases, respiratory and pulmonary diseases, and gynecological diseases; medical diagnostic kits comprised of reagents and assays for testing of samples of a human or animal patient, namely, tissue samples, biopsies, body fluids, smears, skin samples, mucosa samples and hair
- Class 042 — Scientific and technological services: Consultancy and contract research in the field of molecular biology, namely, with regard to the development and optimization of biologically active substances; Custom development of biochemical assay systems on a molecular-biological basis, in particular for research, medicine and environmental analytics; scientific research and development in the field of biologically active substances by means of evolutive biotechnology
Owner
- BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, BERLIN, DE
- DIREVO BioTech AG, Köln, DE
- DIREVO BioTech AG, Köln, DE
Prosecution history
- 08 Aug 2011 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 08 Aug 2011 — ABANDONMENT - NO USE STATEMENT FILED
- 31 Jan 2011 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 31 Jan 2011 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 14 Jan 2011 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Jan 2011 — SOU EXTENSION 3 GRANTED
- 21 Dec 2010 — SOU EXTENSION 3 FILED
- 21 Dec 2010 — SOU TEAS EXTENSION RECEIVED
- 08 Jun 2010 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jun 2010 — SOU EXTENSION 2 GRANTED
- 02 Jun 2010 — SOU EXTENSION 2 FILED
- 02 Jun 2010 — SOU TEAS EXTENSION RECEIVED
- 08 Dec 2009 — SOU EXTENSION 1 GRANTED
- 06 Nov 2009 — SOU EXTENSION 1 FILED
- 08 Dec 2009 — CASE ASSIGNED TO INTENT TO USE PARALEGAL